Loading clinical trials...
Loading clinical trials...
This study will describe the safety and effectiveness of venetoclax in AML patients in routine clinical practice in Israel. The decision to treat with venetoclax is made by the physician prior to any ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT06197672 · Acute Myeloid Leukemia
NCT06285890 · Acute Myeloid Leukemia
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT05429632 · Adult Acute Myeloid Leukemia
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
Meir Medical Center /ID# 213352
Kfar Saba, Central District
Assuta Tel Aviv Medical Center /ID# 213371
Tel Aviv, Central District
HaEmek Medical Center /ID# 213370
Afula, Haifa District
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions